SNY
February 1, 2024 - AI Summary
Undervalued by 5.2% based on the discounted cash flow analysis.
Market cap | $120.74 Billion |
---|---|
Enterprise Value | - |
Dividend Yield | $1.9001 (3.98%) |
Earnings per Share | $2.38 |
Beta | 0.28 |
Outstanding Shares | 2,529,606,602 |
Avg 30 Day Volume | 1,306,318 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 20.22 |
---|---|
PEG | - |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | - |
Enterprise Value to EBIT | - |
Enterprise Value to Net Income | - |
Total Debt to Enterprise | - |
Debt to Equity | - |
No data
No data
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the c...